AFT.NZ
HoldPremium GrowerAFT Pharmaceuticals Limited · Healthcare · New Zealand · $256M
NZD 4.33 +0.7% · close 6 Oct · scored 7 Oct
Premium Grower: Strong business with the market behind it, priced at a premium.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
ABOUT AFT PHARMACEUTICALS LIMITED
Read
AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
FINANCIAL SUMMARY (NZD)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 155.8M | 194.0M | 205.5M | 251.2M | 17.3% | 255.5M | 299.6M | 340.5M | 16.4% |
| EPS (NZD) | 0.10 | 0.15 | 0.11 | 0.14 | 11.9% | 0.14 | 0.19 | 0.24 | 30.0% |
| Shares | 104.9M | 104.9M | 104.9M | 104.9M | 0.0% | 104.9M | — | — | — |
| Debt | 38.0M | 32.2M | 30.0M | 54.1M | 12.5% | 54.3M | — | — | — |
| Equity | 73.3M | 87.8M | 97.6M | 110.3M | 14.6% | — | — | — | — |
| Op CF | 11.6M | 28.9M | 13.2M | -9.5M | 6.4% | -9.6M | — | — | — |
| Inv CF | -9.2M | -9.5M | -7.0M | -9.8M | — | — | — | — | — |
| Fin CF | -7.0M | -10.6M | -6.8M | 8.8M | — | — | — | — | — |
Calmer than 70% of stocks we rank over the past year (31% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AFT.NZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AFT.NZ | AFT Pharmaceuticals Limited(you) | $256M | 60 | Hold |
| ARX.AX | Aroa Biosurgery Limited | $131M | 59 | Hold |
| OCA.NZ | Oceania Healthcare Limited | $310M | 42 | Hold |
| PEB.NZ | Pacific Edge Limited | $190M | 20 | Strong Sell |
| GXH.NZ | Green Cross Health Limited | $166M | 100 | Strong Buy |
| RAD.NZ | Radius Residential Care Limited | $69M | 85 | Strong Buy |
| RYM.NZ | Ryman Healthcare Limited | $1.1B | 34 | Sell |
| SUM.NZ | Summerset Group Holdings Limited | $1.1B | 31 | Sell |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.0B | 76 | Buy |
Peer medians: ROE 10.2% · P/E 14.1x · Gross margin 20.5%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.